These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8185774)

  • 21. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
    Melino S; Paci M
    FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of a pediatric dengue vaccine.
    Shepard DS; Suaya JA; Halstead SB; Nathan MB; Gubler DJ; Mahoney RT; Wang DN; Meltzer MI
    Vaccine; 2004 Mar; 22(9-10):1275-80. PubMed ID: 15003657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects for the therapy and prevention of dengue virus infections.
    Damonte EB; Pujol CA; Coto CE
    Adv Virus Res; 2004; 63():239-85. PubMed ID: 15530563
    [No Abstract]   [Full Text] [Related]  

  • 24. An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.
    Robert Putnak J; Coller BA; Voss G; Vaughn DW; Clements D; Peters I; Bignami G; Houng HS; Chen RC; Barvir DA; Seriwatana J; Cayphas S; Garçon N; Gheysen D; Kanesa-Thasan N; McDonell M; Humphreys T; Eckels KH; Prieels JP; Innis BL
    Vaccine; 2005 Aug; 23(35):4442-52. PubMed ID: 16005749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
    Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
    Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP
    J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S; Pilankatta R; Khanna N; Swaminathan S
    Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dengue vaccine: opportunities and challenges.
    Hatch S; Mathew A; Rothman A
    IDrugs; 2008 Jan; 11(1):42-5. PubMed ID: 18175262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concepts of control of Japanese encephalitis and dengue.
    Shope RE
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 2():131-4. PubMed ID: 9561649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of immunity and protective efficacy of a dengue-3 pre-membrane and envelope DNA vaccine in Aotus nancymae monkeys.
    Blair PJ; Kochel TJ; Raviprakash K; Guevara C; Salazar M; Wu SJ; Olson JG; Porter KR
    Vaccine; 2006 Feb; 24(9):1427-32. PubMed ID: 16214271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folk knowledge about dengue mosquitoes and contributions of health belief model in dengue control promotion in Northeast Thailand.
    Phuanukoonnon S; Brough M; Bryan JH
    Acta Trop; 2006 Aug; 99(1):6-14. PubMed ID: 16945318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dengue, a growing problem of health in the Americas].
    Kourí G
    Rev Panam Salud Publica; 2006 Mar; 19(3):143-5. PubMed ID: 16640842
    [No Abstract]   [Full Text] [Related]  

  • 33. Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts.
    Normile D
    Science; 2013 Oct; 342(6157):415. PubMed ID: 24159024
    [No Abstract]   [Full Text] [Related]  

  • 34. Dengue fever and dengue hemorrhagic fever: a review of the history, transmission, treatment, and prevention.
    Ligon BL
    Semin Pediatr Infect Dis; 2005 Jan; 16(1):60-5. PubMed ID: 15685151
    [No Abstract]   [Full Text] [Related]  

  • 35. First case of Dengue virus infection in Nepal.
    Pandey BD; Rai SK; Morita K; Kurane I
    Nepal Med Coll J; 2004 Dec; 6(2):157-9. PubMed ID: 16295753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards a dengue vaccine: progress to date and remaining challenges.
    Guy B; Almond JW
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):239-52. PubMed ID: 17889365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Perceptions and preventive behavior against dengue fever in Martinique].
    Setbon M; Raude J;
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S78-81. PubMed ID: 18598878
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
    Ramanathan MP; Kuo YC; Selling BH; Li Q; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Oct; 27(46):6444-53. PubMed ID: 19580892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe dengue: the need for new case definitions.
    Rigau-Pérez JG
    Lancet Infect Dis; 2006 May; 6(5):297-302. PubMed ID: 16631550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.